1.31

2.96% -0.04

Telomir Pharmaceuticals Inc (TELO)

Overview News Price History Discussions Forecast

Telomir Pharmaceuticals Inc stock is traded at $1.31, with a volume of 273.04K. It is down -2.96% in the last 24 hours and down -27.22% over the past month. Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Previous Close:

$1.35

Open:

$1.33

24h Volume:

273.04K

Relative Volume:

0.10

Market Cap:

$42.29M

Revenue:

Net Income/Loss:

$-16.14M

P/E Ratio:

-2.4259

EPS:

-0.54

Net Cash Flow:

$-3.99M

1W Performance:

-16.03%

1M Performance:

-27.22%

6M Performance:

-47.39%

1Y Performance:

-68.74%

1-Day Range:

$1.2723

$1.33

1-Week Range:

$1.2723

$1.55

52-Week Range:

$1.12

$7.0791

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name

Telomir Pharmaceuticals Inc

Sector

Healthcare (1134)

Industry

Biotechnology (636)

Phone

786-396-6723

Address

100 SE 2ND ST, MIAMI

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

TELO's Discussions on Twitter

Compare TELO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TELO Telomir Pharmaceuticals Inc	1.31	45.67M	0	-16.14M	-3.99M	-0.54
VRTX Vertex Pharmaceuticals Inc	409.47	105.61B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	657.53	67.99B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	442.70	58.19B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	854.65	52.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.70	39.60B	447.02M	-1.18B	-906.14M	-6.1812

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	Rodman & Renshaw	Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

Nov 07, 2025

Telomir Pharmaceuticals Inc expected to post a loss of 7 cents a shareEarnings Preview - TradingView

Nov 07, 2025

Forecasting Telomir Pharmaceuticals Inc. price range with options dataProduct Launch & Safe Entry Zone Tips - newser.com

Nov 07, 2025

What technical models suggest about Telomir Pharmaceuticals Inc.’s comebackJuly 2025 Rallies & AI Driven Stock Reports - newser.com

Nov 07, 2025

What’s the recovery path for long term holders of Telomir Pharmaceuticals Inc.Earnings Risk Report & Advanced Technical Signal Analysis - newser.com

Nov 07, 2025

Will Telomir Pharmaceuticals Inc. rebound enough to break evenMarket Activity Report & Real-Time Market Trend Scan - newser.com

Nov 07, 2025

Nov 06, 2025

Sentiment analysis tools applied to Telomir Pharmaceuticals Inc.Weekly Trend Summary & Safe Entry Point Alerts - newser.com

Nov 06, 2025

Will Telomir Pharmaceuticals Inc. bounce back from current supportEarnings Miss & Free Reliable Trade Execution Plans - newser.com

Nov 06, 2025

What insider trading reveals about Telomir Pharmaceuticals Inc. stockPortfolio Risk Report & Weekly High Potential Alerts - newser.com

Nov 06, 2025

Analyzing Telomir Pharmaceuticals Inc. with risk reward ratio charts2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com

Nov 06, 2025

How Telomir Pharmaceuticals Inc. stock reacts to global recession fearsWeekly Earnings Recap & Weekly Top Gainers Trade List - newser.com

Nov 06, 2025

Has Telomir Pharmaceuticals Inc. found a price floor2025 Performance Recap & Detailed Earnings Play Strategies - newser.com

Nov 06, 2025

Nov 05, 2025

Momentum divergence signals in Telomir Pharmaceuticals Inc. chart2025 Bull vs Bear & Stock Market Timing Techniques - newser.com

Nov 05, 2025